Metabolites of progesterone in pregnancy: Associations with perinatal anxiety.
Metabolites of progesterone in pregnancy: Associations with perinatal anxiety.
复制标题
怀孕期间黄体酮的代谢:与围产期焦虑的关联。
DOI:
10.1016/j.psyneuen.2023.106327
复制
发表时间:
2023
影响因子:
3.7
通讯作者:
Osborne,LaurenM
中科院分区:
文献类型:
--
作者:
Etyemez,Semra;Miller,KristenN;Voegtline,KristinM;Özdemir,İpek;Standeven,LindsayR;Santovito,LucaSpiro;Pinna,Graziano;Payne,JenniferL;Osborne,LaurenM
BackgroundAnxiety disorders are the most common psychiatric disorder during the perinatal period and one of the major risk factors for postpartum depression, yet we know little about biological factors in the etiology of perinatal anxiety. A growing literature points to neuroactive steroid (NAS) dysregulation in perinatal mental illness, but directionality has not been clearly demonstrated, results are not consistent, and no studies have investigated NAS in a population with pure anxiety without comorbid depression. We aimed to add to the limited literature by examining the association between anxiety without comorbid depression and metabolic pathways of NAS longitudinally across the peripartum.MethodsWe measured anxiety symptoms by psychological scales and NAS levels using Gas Chromatography-Mass Spectrometry (GC-MS) at the second and third trimester (T2 and T3) and week 6 postpartum (W6) in n = 36 women with anxiety and n = 38 healthy controls. The anxiety group was determined by a data-driven approach, and cross-sectional and longitudinal statistical methods were used to examine the relationship between the study population and NAS.ResultsWe found that anxiety had a significant moderating effect on the relationship between progesterone and allopregnanolone, with no such effect for the relationships between progesterone and the intermediate (5α-DHP) or isomeric (isoallopregnanolone) compounds in this pathway, and no effects on the corresponding pathway converting progesterone to pregnanolone and epipregnanolone. We also found a less precipitous decline in the ratio of allopregnanolone to progesterone between T3 and W6 in the anxiety group compared to the non-anxiety group. A genotype analysis of a single-nucleotide polymorphism in the AKR1C2 gene demonstrated that the relationship of allopregnanolone to the intermediate metabolite, 5α-DHP, differed by genotype.ConclusionOur exploratory findings indicate that, for pregnant people with anxiety, metabolism is shunted more aggressively toward the endpoint of the progesterone to allopregnanolone metabolic pathway than it is for those without anxiety.